Tivic Health Systems Inc 2025年季度报告

Log Off Washington, DC 20549 FORM10-Q ☒Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly periodendedSeptember 30, 2025 OR ☐Transmission Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from______ to ______ Commission file number:001-41052 Tivic Health Systems, Inc.(Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 47685 Lakeview Blvd.Fremont,CA94538(Address of principal executive offices including zip code) (888)276-6888(Registrant’s telephone number, including area code) SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT: Trading Symbol(s)TIVC Title of Each ClassCommon Stock, par value $0.0001 per share TheNasdaqStock Market LLC Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file suchreports), and (2) has been subject to such filing requirements for the past 90 days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period thatthe registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smallerreporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smallerreporting company” and “emerging growth company” in Rule 12b‑2 of the Exchange Act (Check one): ☐Large accelerated Filer☐Accelerated Filer☒Non-accelerated Filer☒Smaller reporting company☒Emerging Growth Company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b‑2 of the Exchange Act). Yes☐No☒ As of November 12, 2025 there were1,765,952shares of the registrant’s common stock, par value $0.0001 per share, were issuedand outstanding. Table of Contents Table of Contents PART I - FINANCIAL INFORMATION Item 1.Financial Statements1Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations29Item 3.Quantitative and Qualitative Disclosures about Market Risk42Item 4.Controls and Procedures42 PART II - OTHER INFORMATION PART I - FINANCIAL INFORMATION Item 1. Financial Statements Our condensed financial statements included in this Quarterly Report on Form 10‑Q are as follows: Condensed Balance Sheets as of September30, 2025 (unaudited) and December 31, 20242Condensed Statements of Operations for the three and ninemonths ended September30, 2025 and 2024 (unaudited)3Condensed Statements of Stockholders’Equity for the threeand ninemonths ended September30, 2025 and 2024(unaudited)4Condensed Statements of Cash Flow for the ninemonths ended September30, 2025 and 2024 (unaudited)6Notes to Condensed Financial Statements (unaudited)7 This Quarterly Report on Form 10‑Q (this “Quarterly Report”) for the quarter ended September 30, 2025, should be read inconjunction with the Tivic Health Systems, Inc.’s Annual Report on Form 10‑K for the year ended December 31, 2024, filed withthe Securities and Exchange Commission (the “SEC”) on March 21, 2025. The accompanying condensed financial statements and footnotes have been prepared in accordance with accounting principlesgenerally accepted in the United States of America for interim financial information and the SEC instructions to Form 10‑Q. In theopinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for theinterim period ended September 30, 2025are not necessarily indicative of the results that can be expected for the full year. Tivic Health Systems, Inc.Condensed Balance SheetsSeptember 30, 2025andDecember 31, 2024(in thousands, except share and per share data) Tivic Health Systems, Inc.Condensed Statements of Cash Flows (Unaudited)Nine Months Ended September 30, 2025and2024(in thousands) Tivic Health Systems, Inc.Notes to Unaudited Condensed Financial Statements(amounts are as indicated) 1.Formation and Business of the Company Tivic Health Systems, Inc. (the “Company”) was incorporated in the state of California onSeptember 22, 2016for the purpose ofdeveloping and commercializing non-invasive bioelectronic medicine. InJune 2021,the Company was reincorporated as aDelaware corporationand, inNovember 2021,it completed its initial public offering. In2019,the C